J Ackermann

Bortezomib in relapsed multiple myeloma: response rates and duration of response are independent of a chromosome 13q-deletion

Verena Sagaster, Heinz Ludwig, H. Kaufmann et al. · Leukemia · 2006 · 120 citations

Hematological Malignancy, Chromosome 13Q-deletion, Relapsed Multiple Myeloma +7

Both IGH translocations and chromosome 13q deletions are early events in monoclonal gammopathy of undetermined significance and do not evolve during transition to multiple myeloma

H. Kaufmann, J Ackermann, Catrin Baldia et al. · Leukemia · 2004 · 80 citations

Hematological Malignancy, Cytogenetics, Monoclonal Gammopathy +9

Deletions of chromosome 13q in monoclonal gammopathy of undetermined significance

Robert Königsberg, J Ackermann, H. Kaufmann et al. · Leukemia · 2000 · 70 citations

Cytogenetics, Medicine, Genetics +5

Diffuse large B-cell lymphomas with plasmablastic/plasmacytoid features are associated with TP53 deletions and poor clinical outcome

I Simonitsch-Klupp, I Häuser, German Ott et al. · Leukemia · 2003 · 55 citations

Hematological Malignancy, Lymphoid Neoplasia, Plasmablastic/plasmacytoid Features +8

Expression of the lung resistance protein predicts poor outcome in patients with multiple myeloma.

Martin Filipits, Johannes Drach, Gudrun Pohl et al. · PubMed · 1999 · 44 citations

Poor Outcome, Lung Inflammation, Immunology +16